Latest Organochlorides Stories
- Contrave® net sales total $6.5 million in first 10 weeks of launch SAN DIEGO, Feb. 25, 2015 /PRNewswire/ -- Orexigen Therapeutics, Inc.
Heart Healthy for a Lifetime: Medicationdiscountcard.com Focuses on Access to Coupons for Heart-Related Medications During American Heart Month Houston, TX (PRWEB)
CAMBIA® (Diclofenac Potassium for Oral Solution) is elevated to Level A, based on rigorous clinical data demonstrating its effectiveness for acute migraine attacks, consistent with other therapies
KENILWORTH, N.J., Feb.
-- Approval triggers $3.0 million milestone payment -- SAN DIEGO, Feb. 3, 2015 /PRNewswire/ -- Arena Pharmaceuticals, Inc.
DALLAS, January 30, 2015 /PRNewswire/ -- The report "Pyrethroids Market [http://www.marketsandmarkets.com/Market-Reports/pyrethroids-pesticide-market-170901303.html ] by
Effect Size at 24 Hours More than Double that of Most Other Antidepressant Drugs after 4 to 6 Weeks of Dosing EVANSTON, Ill., Jan.
MOUNTAIN VIEW, Calif., Jan. 22, 2015 /PRNewswire/ -- Alexza Pharmaceuticals, Inc.
Topical research study “Vinyl Chloride (VCM): 2014 World Market Outlook and Forecast up to 2018” elaborated by Merchant Research & Consulting Ltd is now available at mcgroup.co.uk.
Card Enables Eligible Patients to Pay No More than $75 for their BELVIQ Prescription* WOODCLIFF LAKE, N.J., Jan. 20, 2015 /PRNewswire/ -- Eisai Inc.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.